CNTB Connect Biopharma Holdings Ltd

P/E --
Forward P/E 0.767
Price/Sales 578.29
Beta -0.183
Div Yield --
Market Cap --

Company Analysis

Latest News

🟒 CNTB is trading 11.8% up today following an after-hours recovery and recent volatility

CNTB is trading 11.8% up at $2.47 in pre-market following an after-hours recovery and recent volatility. β€’ The stock closed at $2.21 on July 7 after falling...

🟒 CNTB is trading 5.9% up today on after-hours rebound following profit-taking pullback

CNTB is trading at $2.34, up 5.9% in after-hours action, as the stock stages a modest recovery following a decline during the regular session. β€’ The stock...

πŸ”΄ CNTB is trading 5.5% down today on profit-taking after a speculative rally

CNTB is trading 5.5% down at $2.23 as the stock undergoes a pullback following a sharp speculative rally in late June and early July. β€’ The decline appears to...

🟒 CNTB is trading 8.5% up today as it extends its late-June rally despite a lack of fresh news

CNTB is trading at $2.56 (8.5% up) in pre-market, rebounding from yesterday’s 4.1% drop and extending its recent late-June rally. β€’ No fresh company-specific...

πŸ”΄ CNTB is trading 5.3% down today on no clear news catalyst

CNTB is trading at $2.33 (-5.28%) in pre-market action following a quiet news scan that found no clear company-specific catalyst for the move. β€’ The decline...

🟒 CNTB is trading 6% up in pre-market driven by recent biotech momentum and asthma study progress

CNTB is trading at $2.53 (+5.96%) in pre-market after extending its late-June rally. The latest move follows recent momentum in the shares and comes after the...

🟒 CNTB is trading 5% up today, extending recent momentum from late June

CNTB is trading 5% up at $2.50, continuing a multi-day rally as the stock builds on strength established in late June. β€’ The move appears to be a continuation...

🟒 CNTB is trading 5% up today following bullish analyst initiation and recent insider buying

CNTB is trading 5% up at $2.30, extending a multi-day rebound from recent lows as positive analyst coverage and insider activity boost investor sentiment. β€’...

🟒 CNTB is trading 11.4% up today, extending a rebound following recent insider buying

CNTB is trading 11.4% up at $2.44 in pre-market, extending a strong rebound from recent lows despite a lack of fresh company-specific news or filings this...

🟒 CNTB makes sharp 10.9% jump

CNTB is trading at $2.29, up 10.9% versus the comparison close of $2.07 during regular trading. This is a price-movement alert; no separate company-specific...

🟒 CNTB is trading 5.8% up today as Piper Sandler starts coverage with Overweight rating

CNTB is trading 5.8% up at $2.19 after Piper Sandler initiated coverage with a bullish outlook and a $7.00 price target. β€’ Analysts highlighted the company's...

🟒 CNTB Surges 5.6% in Pre-Market on Bullish Analyst Initiation

CNTB is trading 5.6% up at $2.19 in pre-market today. The surge follows Piper Sandler initiating coverage on Connect Biopharma Holdings Ltd with an...

🟒 CNTB is trading 6.9% up today, extending a multi-day rebound from recent lows

CNTB is trading at $2.27 (6.9% up) in pre-market, extending a multi-day rebound from recent lows. β€’ The move appears to be a momentum-driven continuation amid...

🟒 Connect Biopharma Holdings Ltd is trading 13.9% up today despite no clear catalyst

Connect Biopharma Holdings Ltd is trading at $2.28 (13.9% up) in pre-market, rebounding from recent consolidation around the low-$2 range. β€’ The move...

🟒 Connect Biopharma Holdings Ltd is trading 5.8% up today after Phase 2 asthma trial enrollment milestone

Connect Biopharma Holdings Ltd is trading 5.8% up at $2.20 in after-hours trading after announcing the completion of enrollment in its Phase 2 Seabreeze STAT...

🟒 Connect Biopharma Holdings Ltd is trading 7.5% up today after completing enrollment in its Phase 2 Seabreeze STAT Asthma study

Connect Biopharma Holdings Ltd is trading 7.5% up today at $2.14. β€’ The company announced the completion of enrollment in its Phase 2 Seabreeze STAT Asthma...

πŸ”΄ Connect Biopharma Holdings Ltd is trading 5.3% down today as it reverses earlier pre-market gains

Connect Biopharma Holdings Ltd is trading 5.3% down at $1.95 today, giving back earlier pre-market gains that followed a recent momentum-driven move. β€’ The...

🟒 Connect Biopharma Holdings Ltd is trading 5.6% up today extending momentum amid broader risk-on sentiment

Connect Biopharma Holdings Ltd is trading at $2.18 (5.6% up) in pre-market, extending a strong after-hours move from June 15 amid broader risk-on sentiment. β€’...

🟒 Connect Biopharma Holdings Ltd is trading 6.8% up today amid broader market strength and risk-on sentiment

Connect Biopharma Holdings Ltd is trading at $2.20 (6.8% up) in after-hours trading after closing the regular session at $2.06. β€’ The move comes despite a...

πŸ”΄ Connect Biopharma Holdings Ltd is trading 5.2% down today on profit-taking after recent gains

Connect Biopharma Holdings Ltd is trading at $2.01 (5.2% down) as the stock gives back a portion of its recent multi-day gains. β€’ The decline appears to be...